Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
235.83(c) 238.39(c) 239.84(c) 242.68(c) 241.16(c) Last
883 554 1 580 376 1 171 926 1 008 272 1 281 011 Volume
-1.15% +1.09% +0.61% +1.18% -0.63% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 20 003 M - -
Net income 2021 2 231 M - -
Net Debt 2021 14 336 M - -
P/E ratio 2021 31,4x
Yield 2021 1,53%
Sales 2022 19 490 M - -
Net income 2022 2 371 M - -
Net Debt 2022 12 506 M - -
P/E ratio 2022 27,9x
Yield 2022 1,58%
Capitalization 69 259 M 69 259 M -
EV / Sales 2021 4,18x
EV / Sales 2022 4,20x
Nbr of Employees 72 000
Free-Float 78,2%
More Financials
Company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve... 
More about the company
Ratings of Becton, Dickinson and Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about BECTON, DICKINSON AND COMPANY
10/13BECTON DICKINSON AND : BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enh..
PU
10/07BECTON DICKINSON AND : Expands Capacity at Manufacturing Facility in Nebraska
MT
10/07BECTON DICKINSON AND : BD Announces 510(k) Clearance of Expanded Indications for the Rotar..
AQ
10/07BECTON DICKINSON AND : BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Va..
PR
10/06BECTON DICKINSON AND : Receives FDA Clearance of Expanded Indications for Rotarex Atherect..
MT
10/06BECTON DICKINSON AND : BD Announces 510(k) Clearance of Expanded Indications for the Rotar..
PR
10/06Becton, Dickinson and Company Announces 510(k) Clearance of Expanded Indications for th..
CI
10/04BECTON DICKINSON AND : BD To Announce Fiscal 2021 Fourth Quarter And Full Year Financial R..
PR
10/04BECTON DICKINSON & CO : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F..
AQ
09/27BECTON DICKINSON & CO : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
09/27Becton, Dickinson and Company Enters into an Amended and Restated Credit Agreement
CI
09/23BECTON DICKINSON AND : BD Joins the Race to Zero - Largest Alliance Dedicated to Achieving..
AQ
09/22BECTON DICKINSON AND : New BD Cell Analyzer Includes Spectral Analysis Capabilities
PU
09/22BD JOINS THE RACE TO ZERO : Largest Alliance Dedicated to Achieving Net Zero Emissions by ..
PR
09/21BECTON DICKINSON AND : District Of New Jersey Dismisses Putative Class Action Against Medi..
AQ
More news
News in other languages on BECTON, DICKINSON AND COMPANY
09/08VENTE PAR DES INITIÉS : Becton Dickinson &...
09/03VENTE PAR DES INITIÉS : Becton Dickinson & Co.
08/06Hoy en Wall Street: Los datos del empleo de julio superan las estimaciones
08/04L'agenda di domani
08/04L'agenda della settimana
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 241,16 $
Average target price 270,20 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY-3.62%69 259
ABBOTT LABORATORIES7.31%208 288
MEDTRONIC PLC9.06%171 927
HOYA CORPORATION20.71%55 655
DEXCOM, INC.47.27%52 677
SARTORIUS STEDIM BIOTECH60.65%50 025